Medical Education Library

Neuromyelitis Optica Spectrum Disorders:
Critical Role of Complement-Dependent Cytotoxicity


 

This supplement is sponsored by Alexion Pharmaceuticals, Inc.

The complement system was once thought to have a fairly lim­ited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the patho­genesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.

Click here to read the supplement

US/UNB-NMO/17/0002c

Recommended Reading

NORD Seeks Input Regarding Patient Protections and ACA
MDedge Neurology
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Neurology
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Neurology
Apply Now to Join NORD’s Charity Marathon Team
MDedge Neurology
CORD Offers Consensus Framework for Ethical Collaboration
MDedge Neurology
NORD Publishes Report on Spontaneous Intracranial Hypotension (SIH)
MDedge Neurology
Alport Syndrome Foundation Announces Research Funding
MDedge Neurology
Aplastic Anemia & MDS International Foundation Research Portal Is Open
MDedge Neurology
APS Type 1 Symposium Is Planned
MDedge Neurology
Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
MDedge Neurology